MANAGEMENT OF ORAL COMPLICATIONS IN THE PEDIATRIC POPULATION WITH CANCER

소아의 종양성 질환에 동반된 구강합병증 관리

  • Kim, Sung-Ki (Department of Pediatric Dentistry, Pusan National University School of Dentistry) ;
  • Kim, Min-Jeong (Department of Pediatric Dentistry, Pusan National University School of Dentistry) ;
  • Lee, Dong-Soo (Department of Pediatric Dentistry, Pusan National University School of Dentistry) ;
  • Kim, Shin (Department of Pediatric Dentistry, Pusan National University School of Dentistry) ;
  • Jeong, Tae-Sung (Department of Pediatric Dentistry, Pusan National University School of Dentistry)
  • 김성기 (부산대학교 치의학전문대학원 소아치과학교실) ;
  • 김민정 (부산대학교 치의학전문대학원 소아치과학교실) ;
  • 이동수 (부산대학교 치의학전문대학원 소아치과학교실) ;
  • 김신 (부산대학교 치의학전문대학원 소아치과학교실) ;
  • 정태성 (부산대학교 치의학전문대학원 소아치과학교실)
  • Published : 2009.02.27

Abstract

The incidence of childhood cancer is greatest in the first year of life. Early diagnosis and advances in medicine have significantly improved outcomes of treatment resulting in higher survival rate; however, this progress comes at the expense of a higher incidence of adverse side effects because of more aggressive antineoplastic treatment strategies. The oral cavity, a trauma-prone environment, is extremely sensitive to toxicities from antineoplastic agents. Oral health care specialists, including pediatric and hospital dentists can support the oncology team by providing basic oral care, implementing oral care protocols, delivering emergency dental treatment, and assisting and/or managing oral complications from cancer therapy. This article covers the considerations in the dental management of pediatric patients undergoing cancer treatment, specifically chemotherapy, radiotherapy, and hematopoietic stem cell transplantation.

소아의 종양성질환은 출생 첫해에 가장 많고, 2-3세경에 두 번째로 많이 나타난다. 소아에서는 급성 백혈병, 임파선암, 뇌종양, 연조직 종양 그리고 신장 종양이 일반적이다. 조기진단과 의학의 발달로 치료결과가 향상되고 치료후 생존율 또한 높아지는 추세이나, 항암화학요법, 방사선 및 조혈모세포 이식 등의 치료과정에 동반되는 전신 및 국소적합병증 또한 심각한 문제로 나타난다. 구강조직은 항암치료의 독성에 특히 예민하고 구강내 병소가 나타나는 경우가 많다. 소아치과의사는 종양성질환으로 다양한 항암치료를 받는 어린이의 치료 전후에 삶의 질에 영향을 줄 수 있는 치과적 문제를 진단하고 예방 및 관리에 매우 중요한 역할을 담당한다. 따라서 소아치과의사를 포함한 치과종사자는 환자의 병력, 치료과정, 건강상태에 따른 합병증을 예방 또는 처치하기 위한 개별적 구강관리지침을 제공하는 것이 필요하다. 이 논문에서는 소아에서 종양성질환을 치료중인환자, 특히 항암화학요법, 방사선 요법 및 조혈모세포이식환자에 대한 치료전후의 구강관리에 대하여 알아본다.

Keywords

References

  1. 대한소아치과학회 : 소아∙청소년치과학, 4 판, 신흥인터내셔날, 서울, pp.634-642, 2007.
  2. 홍창의 : 소아과학, 7판, 대한교과서(주), 서울, pp.842-852, 2003.
  3. Catherine H. Hong, Marcio da Fonseca. : Consider ations in the pediatric population with cancer. Dent Clin N Am, 52:155-181, 2008. https://doi.org/10.1016/j.cden.2007.10.001
  4. Jemal A, Siegel R, Ward E, et al. : Cancer statistics. CA Cancer J Clin, 57(1):43-66, 2007. https://doi.org/10.3322/canjclin.57.1.43
  5. Morven Miller, BA(Hons), MSc, et al. : Oral care for patients with cancer : a review of the literature. Cancer Nursing, 24:241-254, 2001. https://doi.org/10.1097/00002820-200108000-00001
  6. Curt Goho. : Chemoradiation therapy : effect on dental development. Pediatr Dent, 15:6-12, 1993.
  7. Marcio A. da Fonseca. : Pediatric bone marrow transplantation : oral complications and recommendations for care. Pediatr Dent, 20(7):386-394, 1998.
  8. Berkowitz RJ, Strandjord S, Jones P, et al. Stomatologic complications of bone marrow transplantation in a pediatric population. Pediatr Dent, 9(2):105-110, 1987.
  9. Childers NK, Stinnett EA, Wheeler P, et al. Oral condition in children with cancer. Oral Surg Oral Med Oral Pathol, 75(1):41-47, 1993. https://doi.org/10.1016/0030-4220(93)90404-R
  10. Dahlloff G, Heimdahl A, Bolme P, et al. : Oral condition in children treated with bone marrow transplantation. Bone Marrow Transplantation, 3(1):43-51, 1998.
  11. Fayle SA, Curzon ME. : Oral complications in pediatric oncology patients. Pediatr Dent, 13(5):289-295, 1991.
  12. Kamp AA. : Neoplastic diseases in a pediatric population :a survey of the incidence of oral complications. Pediatr Dent, 10(1):25-29, 1998.
  13. Sonis A, Sonis S. : Oral complications of cancer chemotherapy in pediatric patients. J Pedod, 3(2):122-128, 1979.
  14. Niehaus CS, Meiller TF, Peterson DE, et al. : Oral complications in children during cancer therapy. Cancer Nurs, 10(1):15-20, 1987.
  15. Weisman SJ, Scoopo FJ, Johnson GM, et al. : Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections. J Clin Oncol, 8(3):453-459, 1990.
  16. Graber CJ, de Almeida KN, Atkinson JC, et al. : Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant, 27(5):537-542, 2001. https://doi.org/10.1038/sj.bmt.1702818
  17. Greenberg MS, Cohen SG, McKitrick JC, et al. : The oral flora as a source of septicemia in patients with acute leukemia. Oral Surg Oral Med Oral Pathol , 53(1):32-36, 1982. https://doi.org/10.1016/0030-4220(82)90483-2
  18. Lark RL, McNeil SA, VanderHyde K, et al. : Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients. Clin Infect Dis, 33(3):338-343, 2001. https://doi.org/10.1086/322595
  19. Marron A, Carratala J, Gonzalez-Barca E, et al. : Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer. Clin Infect Dis, 31(5):1126-1130, 2000. https://doi.org/10.1086/317460
  20. Stevenson-Moore P. : Oral complications of cancer therapies. Essential spects of a pretreatment oral examination. NCI Monogr, 9:33-36, 1990.
  21. Brennan MT, von Bultzingslowen I, Schubert MM, et al. : Alimentary mucositis: putting the guidelines into practice. Support Care Cancer, 14(6):573-579, 2006. https://doi.org/10.1007/s00520-006-0054-5
  22. Barker GJ. : Current practices in the oral management of the patients undergoing chemotherapy or bone marrow transplantation. Support Care Cancer, 7(1):17-20, 1999. https://doi.org/10.1007/s005200050217
  23. da Fonseca MA. : Dental care of the pediatric cancer patient. Pediatr Dent 26(1):53-57, 2004.
  24. Peterson DE, Overholser DC. : Increased morbidity associated with oral infection in patients with acute nonlymphocytic leukemia. Oral Surg Oral Med Oral Pathol, 51(4):390-393, 1981. https://doi.org/10.1016/0030-4220(81)90148-1
  25. Loh A, O’Hoy P, Tran X, et al. : Evidence-based assessment: evaluation of the formocresol versus ferric sulfate primary molar pulpotomy. Pediatr Dent, 26(5):401-409, 2004.
  26. Ibricevic H, al-Jame Q. : Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow-up. J Clin Pediatr Dent, 24(4):269-272, 2000.
  27. Raber-Durlacher JE, Epstein JB, Raber J, et al. : Periodontal infection in cancer patients treated with high dose chemotherapy. Support Care Cancer, 10(6):466-473, 2002. https://doi.org/10.1007/s00520-002-0346-3
  28. Peterson DE. : Pretreatment strategies for infection prevention in chemotherapy patients. NCI Monogr, 9:61-71, 1990.
  29. Fayle SA, Curzon ME. : Oral complications in pediatric oncology patients. Pediatr Dent, 13(5):289-295, 1991.
  30. Sheller B, Williams S. : Orthodontic management of patients with hematologic malignancies. AM J Orthod Dentofac Orthop, 109(6):575-580, 1996. https://doi.org/10.1016/S0889-5406(96)70068-9
  31. Baddour LM, Bettmann MA, Bolger AF, et al. : Nonvalvular cardiovascular device-related infections. Circulation, 108:2015-2031, 2003. https://doi.org/10.1161/01.CIR.0000093201.57771.47
  32. Lockhart PB, Brennen MT, Fox PC, et al. : Decision-making on the use of antimicrobial prophylaxis for dental procedures: a survey of infectious disease consultants and review. Clin Infect Dis, 34(12):1621-1626, 2002. https://doi.org/10.1086/340619
  33. National Cancer Institute website. Oral complications of chemotherapy and head/neck radiation. (http://www.cancer.gov/cancertopics/pdq/supportivecare/ oralcomplications/healthprofessional.)
  34. American Academy of Pediatric Dentistry Clinical Affairs Committee; American Academy of Pediatric Dentistry Council on Clinical Affairs. Guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic cell transplantation, and/or radiation. Pediatr Dent, 27(7 Reference Manual):170-175, 2005-2006.
  35. Teruya J. Indications for red cell transfusion in infants and children. Available at: www.Uptodate .com. Accessed May 10, 2007.
  36. Roseff SD, Luban NL, Manno CS. : Guidelines for assessing appropriateness of pediatric transfusion. Transfusion, 42(11):1398-1413, 2002. https://doi.org/10.1046/j.1537-2995.2002.00208.x
  37. Carson JL, Duff A, Berlin JA, et al. : Perioperative blood transfusion and postoperative mortality. JAMA, 279(3):199-205, 1998. https://doi.org/10.1001/jama.279.3.199
  38. Schiffer CA, Anderson KC, Bennett CL, et al. : Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol, 19(5):1519-1538, 2001.
  39. McGuire DB, Correa MEP, Johnson J, et al. : The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer, 14(6):541-547, 2006. https://doi.org/10.1007/s00520-006-0051-8
  40. Borowski B, Benhamou E, Pico JL, et al. : Prevention of oral mucositis in patients treated with high dose chemotherapy and bone marrow transplantation. A randomized controlled trial comparing 2 protocols of dental care. Eur J Cancer B Oral Oncol, 30B(2):93-97, 1994.
  41. Kennedy HF, Morrison D, Tomlinson D, et al. : Gingivitis and toothbrushes: potential rolesin viridans streptococcal bacteraemia. J Infect, 46(1):67-70, 2003. https://doi.org/10.1053/jinf.2002.1084
  42. Addems A, Epstein JB, Damji S, et al. : The lack of efficacy of a foam brush in maintaining gingival health: a controlled study. Spec Care Dentist, 12(3):103-106, 1992. https://doi.org/10.1111/j.1754-4505.1992.tb00423.x
  43. Ransier A, Epstein JB, Lunn R, et al. : Acombined analysis of a toothbrush, foam brush and a chlorhexidine- soaked foam brush in maintaining oral hygiene. Canc Nurs, 18(5):393-396, 1995.
  44. Bellm LA, Epstein JB, Rose-Ped A, et al. : Patient reports of complications of bone marrow transplantation. Support Care Cancer, 8(1):33-39, 2000.
  45. Hedstrom M, Haglund K, Skolin I, et al. : Distressing events for children and adolescents with cancer: child, parent and nurse perceptions. J Pediatr Oncol Nurs, 20(3):120-132, 2003. https://doi.org/10.1053/jpon.2003.76
  46. Berkowitz RJ, Strandjord S, Jones P, et al. : Stomatologic complications of bone marrow transplantation in a pediatric population. Pediatr Dent, 9(2):105-110, 1987.
  47. Childers NK, Stinnett EA, Wheeler P, et al. : Oral complications in children with cancer. Oral Surg Oral Med Oral Pathol, 75(1):41-47, 1993. https://doi.org/10.1016/0030-4220(93)90404-R
  48. Dahlloff G, Heimdahl A, Bolme P, et al. : Oral condition in children treated with bone marrow transplantation. Bone Marrow Transplantation, 3(1):43-51, 1988.
  49. Fayle SA, Curzon ME. : Oral complications in pediatric oncology patients. Pediatr Dent, 13(5):289-295, 1991.
  50. Kamp AA. : Neoplastic diseases in a pediatric population: a survey of the incidence of oral complications. Pediatr Dent, 10(1):25-29, 1988.
  51. Sonis A, Sonis S. : Oral complications of cancer chemotherapy in pediatric patients. J Pedod, 3(2):122-128, 1979.
  52. Niehaus CS, Meiller TF, Peterson DE, et al. : Oral complications in children during cancer therapy. Cancer Nurs, 10(1):15-20, 1987.
  53. Kaste SC, Hopkins KP, Bowman LC, et al. : Dental abnormalities in long-term survivors of head and neck rhabdomyosarcoma. Med Pediatr Oncol, 25(2):96-101, 1995. https://doi.org/10.1002/mpo.2950250209
  54. Fromm M, Littman P, Raney RB, et al. : Late effects after treatment of twenty children with soft tissue sarcomas of the head and neck. Experience at a single institution with a review of the literature. Cancer, 57(10):2070-2076, 1986. https://doi.org/10.1002/1097-0142(19860515)57:10<2070::AID-CNCR2820571032>3.0.CO;2-G
  55. Fleming P, Kinirons MJ : Study of the dental health of children in remission from acute lymphoblastic leukaemia in Northern Ireland. Community Dent Oral Epidemiol, 21(5):309-312, 1993. https://doi.org/10.1111/j.1600-0528.1993.tb00781.x
  56. Goho C : Chemoradiation therapy: effect on dental development. Pediatr Dent, 15(1):6-12, 1993.
  57. Karadzov OM, Sedlecki-Gvozdenovic SD, Demajo M, et al. : The effects of x-ray irradiation of the head region of eight-day-old rats on the development of molar and incisor teeth. Strahlentherapie, 161(7):448-452, 1985.
  58. Dahllof G, Nasman M, Borgstrom A, et al. : Effect of chemotherapy on dental maturity in children with hematological malignancies. Pediatr Dent, 11(4):303-306, 1989.
  59. Alpaslan G, Alpaslan C, Gogen H, et al. : Disturbances in oral and dental structures in patients with pediatric lymphoma after chemotherapy. A preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 87(3):317-321, 1999. https://doi.org/10.1016/S1079-2104(99)70215-5
  60. Holtta P, Alaluusua S, Saarinen-Pihkala UM, et al. : Long term adverse effects on dentition in children with poor-risk neuroblastoma treated with high dose chemotherapy and autologous stem cell transplantation with or without total body irradiation. Bone marrow transplant, 29(2):121-127, 2002. https://doi.org/10.1038/sj.bmt.1703330
  61. Karsila-Tenovuo S, Jahnukainen K, Peltomaki T, et al. : Disturbances in craniofacial morphology in children treated for solid tumors. Oral Oncol, 37(7):586-592, 2001. https://doi.org/10.1016/S1368-8375(01)00002-1
  62. Sonis AL, Tarbell N, Valachovic RW, et al. : Dentofacial development in long-term survivors of acute lymphoblastic leukemia. A comparison of three treatment modalities. Cancer, 66(12):2645-2652, 1990. https://doi.org/10.1002/1097-0142(19901215)66:12<2645::AID-CNCR2820661230>3.0.CO;2-S
  63. Raney RB, Asmar L, Vassilopoulou-Sellin R. et al. : Late complications of therapy in 213 children with localized, nonorbital soft tissue sarcoma of the head and neck: a descriptive report from the intergroup rhabdomyosarcoma studies (IRS)-II and III. Med Pediatr Oncol, 33(4):362-371, 1999. https://doi.org/10.1002/(SICI)1096-911X(199910)33:4<362::AID-MPO4>3.0.CO;2-I
  64. Nieuw Amerongen AV, Veerman EC. : Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer, 11(4):226-231, 2003.
  65. Vissink A, Burlage FR, Spijkervet KF, et al. : Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med, 14(3):213-225, 2003. https://doi.org/10.1177/154411130301400306
  66. Vissink A, Jansma J, Spijkervet FK, et al. : Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med, 14(3):199-212, 2003. https://doi.org/10.1177/154411130301400305
  67. Scaradavou A, Heller G, Sklar CA, et al. : Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma. Cancer, 76(10):1860-1867, 1995. https://doi.org/10.1002/1097-0142(19951115)76:10<1860::AID-CNCR2820761027>3.0.CO;2-I
  68. Cohen RJ, Curtis RE, Inskip PD, et al. : The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer, 103(11):2391-2396, 2005. https://doi.org/10.1002/cncr.21040
  69. Nasman M, Bjork O, Soderhall S, et al. : Disturbances in the oral cavity in pediatric longterm survivors after different forms of antineoplastic therapy. Pediatr Dent, 16(3):217-223, 1994.
  70. Schubert MM, Peterson DE, Lloid ME. et al. : Oral complications. Hematopoietic cell transplantation. 2nd edition. Malden (MA): Blackwell Science; p. 751-63, 1999.
  71. Dahllof G, Jonsson A, Ulmmer M, et al. : Orthodontic treatment in long-term survivors after pediatric bone marrow transplantation. Am J Orthod Dentofacial Orthop, 120(5):459-465, 2001. https://doi.org/10.1067/mod.2001.118102
  72. Shaw L, Glenwright HD. : The role of medications in dental caries formation: need for sugar-free medication for children. Pediatrician, 16(3-4):153-155, 1989.